Novo Nordisk
Elnara Fazio-Eynullayeva has extensive experience in health economics and outcomes research, serving as Associate Director at Novo Nordisk from July 2022 to January 2024, following a role as Manager of Evidence Generation. Prior to Novo Nordisk, Elnara worked at TriNetX as Principal Research Scientist and Associate Epidemiologist from October 2019 to June 2022. Elnara's career includes a position as Senior Research Associate at Harvard Pilgrim Health Care Institute from January 2017 to October 2019, and as Senior Associate in Advanced Analytics at Trinity Partners between May 2014 and January 2017. Elnara began a career in research as a Research Analyst at Truven Health Analytics® from June 2010 to May 2014. Elnara holds a Master’s degree in Economics from the University of Connecticut and a Bachelor’s degree in Economics and Japanese language and literature from the University of Massachusetts Amherst.
This person is not in any teams
This person is not in any offices
Novo Nordisk
376 followers
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.